Analytical Data
-
基因名
ANKRD45
- Application
-
别名
ANKRD45; ankyrin repeat domain 45; Ankyrin repeat domain containing Protein 45
-
种属
Human
-
表达系统
E. coli
-
标签
GST-tag at N-terminal
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q5TZF3
-
表达区间
1-266aa
-
氨基酸序列
MESEGPPESESSEFFSQQEEENEEEEAQEPEETGPKNPLLQPALTGDVEGLQKIFEDPENPHHEQAMQLLLEEDIVGRNLLYAACMAGQSDVIRALAKYGVNLNEKTTRGYTLLHCAAAWGRLETLKALVELDVDIEALNFREERARDVAARYSQTECVEFLDWADARLTLKKYIAKVSLAVTDTEKGSGKLLKEDKNTILSACRAKNEWLETHTEASINELFEQRQQLEDIVTPIFTKMTTPCQVKSAKSVTSHDQKRSQDDTSN
-
分子量
56.4 KDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
ANKRD45, a member of the ankyrin repeat-containing protein family, has garnered considerable attention in recent years due to its potential roles in various cellular processes and its involvement in human diseases. These proteins are characterized by the presence of multiple ankyrin repeats, which typically mediate protein-protein interactions, thus playing critical roles in cellular signaling, cytoskeletal organization, and gene regulation. Recent studies have suggested that ANKRD45 may be implicated in pathological conditions, including cancer and neurodegenerative diseases, highlighting its significance as a therapeutic target. To better understand its biological functions and mechanisms of action, researchers have turned to recombinant protein technology, enabling the production of purified ANKRD45 for in-depth biochemical and structural studies. This research aims to elucidate the protein's interaction partners, post-translational modifications, and its role in disease pathology, ultimately paving the way for the development of targeted therapies. As the field progresses, characterizing ANKRD45 through recombinant expression systems may provide valuable insights into its functions and contributions to health and disease, making it a promising candidate for future therapeutic interventions.
